Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
---|
06/13/2012 | CN101824066B Method for preparing rocuronium bromide midbody compound crystal |
05/31/2012 | US20120135065 Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome |
05/30/2012 | CN102477061A 吡啶雄甾衍生物及其在制备预防和/或治疗前列腺癌药物中的用途 Pyridine-androstene derivatives and their use in the manufacture of prevention and / or treatment of prostate cancer medicament |
05/23/2012 | CN101704871B Steroid compound and application thereof |
05/22/2012 | CA2614667C 20-keto-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
05/16/2012 | EP1888615B1 17 -hsd1 and sts inhibitors |
05/10/2012 | US20120115169 Hydroxycholesterol immunoassay |
05/09/2012 | EP1480960B1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments |
05/09/2012 | CN102448978A Novel Glucocorticoid Receptor Agonists |
05/02/2012 | CN102432662A Crystal form of pipecuronium bromide, preparation method and application of crystal form |
05/02/2012 | CN102432661A Method for preparing high-purity etioline |
04/18/2012 | CN101732730B 含咪唑嗡盐和大环多胺的阳离子脂质、转基因载体及制备方法 Om imidazole-containing macrocyclic polyamine salts and cationic lipids, gene transfer vector and preparation methods |
04/04/2012 | EP2435462A1 Novel glucocorticoid receptor agonists |
03/22/2012 | US20120071453 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
03/21/2012 | CN102382164A Toad lactam compound as well as preparation method and application thereof |
03/14/2012 | EP2428519A2 Process for the preparation of 17-vinyl- triflates as intermediates |
03/14/2012 | EP2427472A1 Lipophilic polynucleotide conjugates |
03/14/2012 | CN102372762A Novel technology for synthesizing pregnene 11-site beta-hydroxy |
03/14/2012 | CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity |
03/06/2012 | CA2560694C Progesterone receptor modulators |
03/01/2012 | US20120053340 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
03/01/2012 | US20120053163 Steroids as Agonists for FXR |
03/01/2012 | US20120053162 Certain chemical entities, compositions, and methods |
02/29/2012 | EP2421882A2 Angiogenesis inhibitors |
02/23/2012 | US20120046461 Steroidal anti-hormone hybrids |
02/22/2012 | CN102358750A Helix 12 directed pharmaceutical products |
02/22/2012 | CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors |
02/15/2012 | EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group |
02/15/2012 | CN102353661A Fluorescent sensor film preparation method based on perylene diimide cholesterol derivative |
02/08/2012 | CN102344480A Method for synthesizing dendritic aminosterol substance |
02/08/2012 | CN102344479A Preparation method of quaternary ammonium salts of methyl ammonium bromide |
02/01/2012 | CN102336801A Abiraterone acetate polymorphic substance and pharmaceutical composition |
01/26/2012 | WO2012011106A1 Process for the preparation of 17-desoxy-corticosteroids |
01/24/2012 | CA2163748C Methods and compositions for inducing sleep |
01/18/2012 | CN102321142A Abiraterone acetate crystal form and preparation method thereof |
01/18/2012 | CN102321140A Lipoid cation function molecule synthesized from natural cholesterol and amino acid and preparation method and application thereof |
01/12/2012 | US20120010173 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations |
01/12/2012 | DE102010027016A1 New steroid-styryl dye conjugates useful e.g. for simulation and direct light optical detection of the behavior of steroid in the living biological tissue in the presence of a steroid binding protein |
01/10/2012 | US8093233 Agent for inhibiting visceral fat accumulation |
01/10/2012 | CA2454339C Methods for preventing antipsychotic-induced weight gain |
01/03/2012 | US8088758 17β-hydroxysteroid dehydrogenase type I inhibitors |
12/22/2011 | US20110312926 2-(N-Substituted Piperazinyl) Steroid Derivatives |
12/22/2011 | US20110312924 Novel steroidal cyp17 inhibitors/antiandrogens |
12/22/2011 | US20110312916 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
12/21/2011 | CN102286053A 孕甾烯醇酮吡咯化合物及其制备方法 Pregnenolone azole compound and its preparation method |
12/20/2011 | US8080540 Therapeutically active triazoles and their use |
12/14/2011 | EP2393827A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
12/13/2011 | US8076474 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
11/30/2011 | EP2390260A2 Ester derivative of ethinyl estradiol |
11/24/2011 | US20110288288 Process for the preparation of 17-0-vinyl- triflates as intermediates |
11/23/2011 | CN101130567B Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
11/16/2011 | EP1781683B1 Process for the preparation of 17-vinyl- triflates as intermediates |
11/15/2011 | US8058267 Steroids as agonists for FXR |
11/10/2011 | US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
11/02/2011 | CN102229636A New derivatives of berberine coupled with cholic acid at ninth position through ester bond and preparation methods thereof |
10/27/2011 | WO2011098437A3 Progesterone receptor antagonists |
10/27/2011 | US20110262368 C21 thioethers as glucocorticoid receptor agonists |
10/26/2011 | CN102225962A New derivative bonded by berberine and cholic acid at 9th position of berberine and preparation method thereof |
10/26/2011 | CN102225961A Novel berberine 9-position coupled cholic acid derivative and preparation method thereof |
10/20/2011 | WO2011098436A3 Progesterone receptor antagonists |
10/12/2011 | EP2373674A1 2-(n-substituted piperazinyl) steroid derivatives |
10/11/2011 | CA2481561C Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
10/04/2011 | US8030482 Free cholesterol analogs bearing a boron dipyrromethene difluoro (BODIPY) fluorophore in the side chain and method of preparation and use thereof |
09/22/2011 | WO2011059969A3 Mammalian metabolites of steroids |
09/22/2011 | US20110229581 Releasable cationic lipids for nucleic acids delivery systems |
09/07/2011 | CN101260136B Oestrogen derivatives as inhibitors of steroid sulphatase |
09/01/2011 | US20110212935 Compositions and treatment methods-4 |
08/31/2011 | CN102167718A 16-imidazole substitute-3amine substitute-5 alpha androstane derivatives and preparation method and application thereof |
08/25/2011 | US20110207154 Method for determination of marinobufagenin levels and compounds employable in such method |
08/24/2011 | CN102161688A Cholesterol-structure-fragment-containing biocompatible synthesis liposomes as well as preparation method and application thereof |
08/18/2011 | US20110200582 Lipids, lipid compositions, and methods of using them |
08/18/2011 | CA2789240A1 Progesterone receptor antagonists |
08/18/2011 | CA2789237A1 Progesterone receptor antagonists |
08/17/2011 | CN101218245B 3-ester prodrugs of ethynylestradiol |
08/11/2011 | DE102010007722A1 Progesteronrezeptorantagonisten Progesterone receptor antagonists |
07/28/2011 | WO2011089541A1 Methods for intracellular delivery of nucleic acids |
07/28/2011 | US20110182828 C20-c21 substituted glucocorticoid receptor agonists |
07/28/2011 | CA2786766A1 Methods for intracellular delivery of nucleic acids |
07/27/2011 | EP2348032A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
07/27/2011 | EP2348031A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
07/27/2011 | EP2348030A2 17-Alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
07/20/2011 | EP2345732A1 Methods for intracellular delivery of nucleic acids |
07/12/2011 | CA2279971C Androgen synthesis inhibitors |
07/07/2011 | US20110165225 Modified Drugs for Use in Liposomal Nanoparticles |
06/30/2011 | CA2785492A1 Lipids, lipid compositions, and methods of using them |
06/16/2011 | US20110144075 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
06/15/2011 | CN102099368A C-21 thioethers as glucocorticoid receptor agonists |
06/15/2011 | CN102093455A 16-substituted-3heterocycle-5alpha androstane derivative, and preparation method and application thereof |
06/14/2011 | CA2512987C 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
06/14/2011 | CA2458267C Bifunctional chelating agent for actinium |
06/07/2011 | CA2628607C Androgen synthesis inhibitors |
06/01/2011 | CN102083850A Selective high-affinity polydentate ligands and methods of making such |
06/01/2011 | CN102083849A Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
06/01/2011 | CN102079771A Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof |
05/31/2011 | US7951965 Having semiconductor properties of electron transfer, electroluminescence, and photoluminescence. Intermolecular stacking can be avoided, enhanced electron-luminescent emission stability, applied as a light-emitting material in organic EL devices |
05/24/2011 | US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
05/19/2011 | US20110118225 Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them |
05/19/2011 | CA2780365A1 Mammalian metabolites of steroids |
05/11/2011 | CN101597315B Organic metal coordination compound gelator and luminous gel composed of same |
05/10/2011 | CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides |